Evidence map›Paper›PMID 25799263›Full record

ArticlePloS one2015

Evaluation of the Versant CT/GC DNA 1.0 assay (kPCR) for the detection of extra-genital Chlamydia trachomatis and Neisseria gonorrhoeae infections.

Antonella Marangoni, Claudio Foschi, Paola Nardini, Monica Compri, Roberto Cevenini

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. BMJ open · 2025
    Article
  2. Anti-chlamydial activity of vaginal fluids: new evidence from anFrontiers in cellular and infection microbiology · 2024
    Article
  3. Article
  4. Whole Genome Sequencing of aCurrent issues in molecular biology · 2023
    Article
  5. First-Void Urine Microbiome in Women withInternational journal of molecular sciences · 2022
    Article
  6. A Deep Look at the Vaginal Environment During Pregnancy and Puerperium.Frontiers in cellular and infection microbiology · 2022
    Article
  7. Article
  8. Article
  9. Distribution ofPathogens (Basel, Switzerland) · 2021
    Article
  10. Vaginal and Anal Microbiome duringPathogens (Basel, Switzerland) · 2021
    Article
  11. Article
  12. Meningococcal Carriage in 'Men Having Sex With Men' With Pharyngeal Gonorrhoea.Frontiers in cellular and infection microbiology · 2021
    Article
  13. Article
  14. Rectal Microbiota Associated WithFrontiers in cellular and infection microbiology · 2019
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Antonella MarangoniMicrobiology, Experimental Diagnostic and Specialty Department (DIMES), University of Bologna, Bologna, Italy.
Claudio FoschiMicrobiology, Experimental Diagnostic and Specialty Department (DIMES), University of Bologna, Bologna, Italy.
Paola NardiniMicrobiology, Experimental Diagnostic and Specialty Department (DIMES), University of Bologna, Bologna, Italy.
Monica CompriMicrobiology, Experimental Diagnostic and Specialty Department (DIMES), University of Bologna, Bologna, Italy.
Roberto CeveniniMicrobiology, Experimental Diagnostic and Specialty Department (DIMES), University of Bologna, Bologna, Italy.
University of Bologna · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Screening for extra-genital Chlamydia trachomatis and Neisseria gonorrhoeae infections is a crucial component for sexually transmitted diseases management, even if at present days no commercial methods have been approved for use on pharyngeal and rectal specimens by the US FDA or have received the conformity CE marking. Here we report the analytical sensitivities of the Versant CT/GC 1.0 assay (Siemens Healthcare Diagnostics, Tarrytown, NY, USA) on rectal and pharyngeal swabs, and an evaluation about the suitability for this assay with two widely used swab collection devices (E-Swab and eNAT, Copan, Brescia, Italy). The limits of detection for rectal and pharyngeal specimens with the Versant assay were 10 copies/ml and 1.0 copies/ml, for C. trachomatis and N. gonorrhoeae, respectively. False positive results due to the presence of non-gonococcal Neisseria species were excluded when clinical rectal and pharyngeal samples containing organisms identified as N. meningitidis, N. sicca, N. flavescens and N. subflava were tested. Due to its sensitivity and specificity, the Versant assay represents a good choice for the diagnosis of chlamydial and/or gonococcal infections not only in genito-urinary samples, but also on rectal and pharyngeal swabs.

Indexed as

Chlamydia InfectionsChlamydia trachomatisGonorrheaHumansNeisseria gonorrhoeaeNucleic Acid Amplification TechniquesPolymerase Chain ReactionReagent Kits, DiagnosticSensitivity and SpecificityReagent Kits, Diagnostic

Identifiers

PMID25799263
PMCPMC4370730
OpenAlexW2019526947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.